However, according to a number of studies, the introduction of PSA screening causes the rate of overdiagnosis of PCa to reach almost 50%; moreover, when the threshold for PSA is in the range 2.5–4 ng/mL, the level of overdiagnosis can reach 80% [4]. The gene discussed is KLK3; the disease is posterior cortical atrophy.